Use of Second-Generation Antidiabetic Medication Among a Nationally Representative Sample
October 19th 2023Among individuals with a diagnosis of type 2 diabetes across the United States, income level, hemoglobin A1c, and comorbidity burden were the primary patient-level drivers of the use of newer antidiabetic agents.